Metraipolis › archive › dc_07dd22d2fefe

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model — Europe PMC PMID:41988121

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41988121
DOI: 10.3389/fonc.2026.1721685
License (as archived): solo-consultazione
Archived: 2026-11-03T15:09:34.787Z
SHA-256 of the archived text: 9215f10df1a649ad9795450f5141d61f5081bf587ebb024cd59265c0d05f24d1
Stable URL of this page: https://metraipolis.com/documento/dc_07dd22d2fefe

How to cite

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model — Europe PMC PMID:41988121 — Europe PMC (en), https://europepmc.org/article/MED/41988121 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07dd22d2fefe (Metraipolis archive dc_07dd22d2fefe, sha256 9215f10df1a649ad9795450f5141d61f5081bf587ebb024cd59265c0d05f24d1)

BibTeX

@misc{dc07dd22d2fefe,
  title = {Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model — Europe PMC PMID:41988121},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41988121},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07dd22d2fefe; sha256 9215f10df1a649ad9795450f5141d61f5081bf587ebb024cd59265c0d05f24d1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41988121. Agents can read the archived copy with the MCP tool read_document.